×
For best experience we recommend to activate Javascript in your browser.
TACSTD2 antibody (AA 25-270)
This anti-TACSTD2 antibody is a Rabbit Polyclonal antibody detecting TACSTD2 in WB, IHC, ICC and IP. Suitable for Mouse.
Quick Overview for TACSTD2 antibody (AA 25-270) (ABIN7629054)
Target
See all TACSTD2 Antibodies
TACSTD2
(Tumor-Associated Calcium Signal Transducer 2 (TACSTD2))
Reactivity
All reactivities for TACSTD2 antibodies
Mouse
Host
All hosts for TACSTD2 antibodies
Rabbit
Clonality
All clonalities for TACSTD2 antibodies
Polyclonal
Conjugate
All conjugates for TACSTD2 antibodies
This TACSTD2 antibody is un-conjugated
Application
All applications for TACSTD2 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP)
Product Details anti-TACSTD2 Antibody
(hide)
Binding Specificity
All epitopes for TACSTD2 antibodies
AA 25-270
Purpose
Tumor Associated Calcium Signal Transducer 2 (TACSTD2) Polyclonal Antibody
Sequence
Gln25~Gly270
Characteristics
The Tumor Associated Calcium Signal Transducer 2 (TACSTD2) Polyclonal Antibody (Species: Mouse) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for TACSTD2
(hide)
Target
TACSTD2
(Tumor-Associated Calcium Signal Transducer 2 (TACSTD2))
Alternative Name
TACSTD2
Gene ID
56753
UniProt
Q8BGV3
Recently viewed
(hide)
Chat with us , powered by LiveChat